Department of Health and Social Care written question – answered on 20th July 2021.

Alert me about debates like this

Photo of Lord Stone of Blackheath Lord Stone of Blackheath Non-affiliated

To ask Her Majesty's Government what consideration they have given to the (1) licensing, and (2) use, of Ivermectin in both the (a) treatment, and (b) prevention, of COVID-19.

Photo of Lord Bethell Lord Bethell The Parliamentary Under-Secretary for Health and Social Care

The Department is closely monitoring the evidence on the case for using ivermectin for the treatment and prevention of COVID-19. Licensing of ivermectin is dependent on application to the Medicines and Healthcare products Regulatory Agency for authorisation. We are continuing to monitor for new data from trials worldwide, including the UK PRINCIPLE clinical trial platform, which announced on 23 June that ivermectin would be investigated to generate robust data on its effectiveness in treating adults aged 18 years old and over who are at higher risk of serious illness from COVID-19.

Does this answer the above question?

Yes2 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.